SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

WhatsApp billionaire Jan Koum donates $200 million to Jerusalem hospital Shaare Zedek

Batsheva Moshe appointed GM Israel market & EMEA tech at Kaltura

AstraZeneca expands AI partnership with Immunai in deal worth up to $37.5 million

The strong shekel is becoming Israel’s next economic crisis

Buzz

Most popular

Daily

Weekly

1

From defense giants to startups: Israel reconsiders how it buys weapons

2

Five bidders advance in Nice’s $2.5 billion Actimize sale process

3

Kela raising $200 million at $1 billion valuation with backing from Bill Ackman and Eric Schmidt

4

Cisco acquires AI security startup Astrix for $400 million

5

The 50 most promising Israeli startups - 2026

Weight Loss

4 stories about Weight Loss

גלולת הרזיה של אפיטומי

Epitomee surges 200% in two days on FDA approval for weight loss pill

16.09.24|Adiel Eithan Mustaki

Investors are hopeful, but the company must now face an uphill battle in a crowded market.

גלולת הרזיה של אפיטומי

Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement

04.12.23|Adiel Eithan Mustaki

The Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level

גלולה של חברת אפיטומי epitomee

Weight loss pill success sparks stock surge at Epitomee Medical

04.09.23|Adiel Eithan Mustaki

The company, which has not yet published the full results of its study, plans to seek FDA approval via the 510(k) pathway

מוסף תרופה תרופות בית מרקחת

Teva Israel to Stop Distribution of Weight Loss Drug Amid Cancer Concerns

16.02.20|Lilach Baumer

On Thursday, the manufacturer of Belviq weight loss drug, Eisai, announced it was withdrawing the drug from the U.S. market after a five-year trial found it increased risk of cancer by 0.6%